Cita APA

Hakimi, Z., Kelleher, C., Aballéa, S., Maman, K., Nazir, J., Mankowski, C., & Odeyemi, I. (2018). Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK. J Mark Access Health Policy.

Chicago Style Citation

Hakimi, Zalmai, Con Kelleher, Samuel Aballéa, Khaled Maman, Jameel Nazir, Colette Mankowski, i Isaac Odeyemi. "Cost-effectiveness of Solifenacin Compared With Oral Antimuscarinic Agents for the Treatment of Patients With Overactive Bladder in the UK." J Mark Access Health Policy 2018.

Cita MLA

Hakimi, Zalmai, et al. "Cost-effectiveness of Solifenacin Compared With Oral Antimuscarinic Agents for the Treatment of Patients With Overactive Bladder in the UK." J Mark Access Health Policy 2018.